selected scholarly activity
-
academic article
- Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82. European Urology. 80:e77-e78. 2021
- Update on Molecular Imaging and Precision Medicine in Lung Cancer. Radiologic Clinics of North America. 59:693-703. 2021
- Detecting lumbar lesions in 99m Tc‐MDP SPECT by deep learning: Comparison with physicians. Medical Physics. 48:4249-4261. 2021
- Overview of the First NRG Oncology–National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 62:1133-1139. 2021
- Case – 18F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging. Journal of the Canadian Urological Association. 15:E376-E379. 2021
- Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician’s guide. Expert Review of Anticancer Therapy. 21:641-655. 2021
- Case – Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation. Journal of the Canadian Urological Association. 15. 2021
- Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative. Clinical Nuclear Medicine. Publish Ahead of Print:616-620. 2021
- Internal Jugular Vein and Cerebral Venous Sinus Infective Thrombophlebitis Detected With 99mTc-HMPAO White Blood Cell Scintigraphy. Clinical Nuclear Medicine. 46:e112-e113. 2021
- Machine Learning in Nuclear Medicine: Part 2—Neural Networks and Clinical Aspects. Journal of Nuclear Medicine. 62:22-29. 2021
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 62:6-14. 2021
- Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging. Advances in Radiation Oncology. 6:100553-100553. 2021
- Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer. Radiology. 296:573-574. 2020
- Prostate Cancer Lymphangitic Pulmonary Carcinomatosis. Clinical Nuclear Medicine. 45:727-729. 2020
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer's and Dementia. 16:1182-1195. 2020
- The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score. Clinical Nuclear Medicine. 45:427-433. 2020
- A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy. Journal of the Canadian Urological Association. 14:130-138. 2020
- A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. International Journal of Radiation Oncology Biology Physics. 106:546-555. 2020
- Clinical and Technical Considerations for Brain PET Imaging for Dementia. Journal of Nuclear Medicine Technology. 48:5-8. 2020
- Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism. JAMA Internal Medicine. 179:1738-1738. 2019
- The Use of Random Forests to Classify Amyloid Brain PET. Clinical Nuclear Medicine. 44:784-788. 2019
- Fifth Anniversary of SNMMI Professional Relations Fellowship.. Journal of Nuclear Medicine. 60:20N. 2019
- Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network. Journal of Nuclear Medicine. 60:677-682. 2019
- An International Survey of PET/CT Clinical Reporting. Journal of Nuclear Medicine. 60:478-479. 2019
- Machine Learning in Nuclear Medicine: Part 1—Introduction. Journal of Nuclear Medicine. 60:451-458. 2019
- Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?. Journal of Nuclear Medicine. 60:158-166. 2019
- 18F-DCFPyL PET/CT in Oncocytoma. Clinical Nuclear Medicine. 43:921-924. 2018
- Update 2018. Clinical Nuclear Medicine. 43:e439-e452. 2018
- A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer. Prostate. 78:1053-1062. 2018
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy. Clinical Oncology Comparative Haematology International. 30:658-666. 2018
- PET/CT of Dementia. American Journal of Roentgenology. 211:246-259. 2018
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. Annals of Internal Medicine. 168:459-459. 2018
- Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations.. Clinical Nuclear Medicine. 43:213-216. 2018
- Pulmonary nodules as incidental findings. CMAJ. 190:E167-E167. 2018
- Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. Journal of Nuclear Medicine. 58:2026-2037. 2017
- Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers. PET Clinics. 12:393-405. 2017
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. Annals of Internal Medicine. 167:341-341. 2017
- Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 58:1264-1269. 2017
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline. Clinical Oncology Comparative Haematology International. 29:348-355. 2017
- Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 18:259-273.e8. 2017
- Desirable Properties of Radiopharmaceuticals for Sentinel Node Mapping in Patients With Breast Cancer Given the Paradigm Shift in Patient Management. Clinical Nuclear Medicine. 42:275-279. 2017
- Joint reconstruction of Ictal/inter-ictal SPECT data for improved epileptic foci localization. Medical Physics. 44:1437-1444. 2017
- Self-management education interventions for patients with cancer: a systematic review. Supportive Care in Cancer. 25:1323-1355. 2017
- A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23:935-945. 2017
- Molecular Imaging and Precision Medicine in Lung Cancer. PET Clinics. 12:53-62. 2017
- Response Assessment Criteria and Their Applications in Lymphoma: Part 2. Journal of Nuclear Medicine. 58:13-22. 2017
- SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer. Journal of Nuclear Medicine. 58:11-12. 2017
- Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review. Cancer Treatment Reviews. 51:35-45. 2016
- Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy. Surgical Oncology. 25:92-97. 2016
- Response Assessment Criteria and Their Applications in Lymphoma: Part 1. Journal of Nuclear Medicine. 57:928-935. 2016
- Diagnosing dementia. CMAJ. 188:603-603. 2016
- Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:225-232. 2016
- Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World. JACC: Cardiovascular Imaging. 9:376-384. 2016
- Imaging Biomarkers in Immunotherapy. Biomarkers in Cancer. 8s2:BIC.S31805-BIC.S31805. 2016
- Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomarkers in Cancer. 8s2:BIC.S31804-BIC.S31804. 2016
- Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy. Journal of Nuclear Medicine. 56:1119-1129. 2015
- [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments. Translational Oncology. 8:147-153. 2015
- Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. 41:2346-2353. 2014
- Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17:325-331. 2014
- Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma. Cancer Imaging. 14:30. 2014
- 18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 55:1473-1480. 2014
- Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:717-e390. 2014
- Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.. Canadian Family Physician. 60:711-e382. 2014
- Systematic review of clinical features of suspected colorectal cancer in primary care.. Canadian Family Physician. 60:e405-e415. 2014
- Systematic review of guidelines for the management of suspected lung cancer in primary care.. Canadian Family Physician. 60:e395-e404. 2014
- Abdomen. PET Clinics. 9:169-183. 2014
- Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging. Journal of Nuclear Medicine. 55:337-348. 2014
- Imaging in Prostate Carcinoma. Hematology/Oncology Clinics of North America. 27:1163-1187. 2013
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin. Journal of Clinical Oncology. 31:3182-3190. 2013
- Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdominal Imaging Gastrointestinal Radiology. 38:728-735. 2013
- Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 54:1237-1243. 2013
- Update on Imaging of Vulvar Squamous Cell Carcinoma. American Journal of Roentgenology. 201:W147-W157. 2013
- Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging. Journal of Nuclear Medicine. 54:756-761. 2013
- Imaging Features of Primary and Secondary Adult Rhabdomyosarcoma. American Journal of Roentgenology. 199:W694-W703. 2012
- MRI for Evaluation of Myeloid Sarcoma in Adults: A Single-Institution 10-Year Experience. American Journal of Roentgenology. 199:1193-1198. 2012
- Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management. American Journal of Roentgenology. 199:1259-1265. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 1, Primary Pathology. American Journal of Roentgenology. 199:W163-W167. 2012
- PET/CT and Renal Pathology: A Blind Spot for Radiologists? Part 2—Lymphoma, Leukemia, and Metastatic Disease. American Journal of Roentgenology. 199:W168-W174. 2012
- Multimodality imaging in amyloidosis. Cancer Imaging. 12:109-117. 2012
- Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 12:100-108. 2012
- Pheochromocytoma and paraganglioma: nimaging characteristics. Cancer Imaging. 12:153-162. 2012
- Reduction in Radiation Dose in Mercaptoacetyltriglycerine Renography with Enhanced Planar Processing. Radiology. 261:907-915. 2011
- FDG Uptake in Lipomatous Hypertrophy of the Interatrial Septum Is Not Likely Related to Brown Adipose Tissue. Clinical Nuclear Medicine. 36:767-769. 2011
- Imaging in Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 25:687-715. 2011
- Abscopal Effect in a Patient With Metastatic Merkel Cell Carcinoma Following Radiation Therapy: Potential Role of Induced Antitumor Immunity. Archives of Dermatology. 147:870-870. 2011
- Imaging of Liposarcoma: Classification, Patterns of Tumor Recurrence, and Response to Treatment. American Journal of Roentgenology. 197:W37-W43. 2011
- Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging. Pediatric Radiology. 41:759-768. 2011
- Nuclear Medicine in the First Year of Life. Journal of Nuclear Medicine. 52:905-925. 2011
- End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma. Annals of Oncology. 22:910-915. 2011
- Imaging assessment of pars interarticularis injury in young athletes with back pain: current concepts and imaging methods. ArgoSpine News and Journal. 23:15-18. 2011
- Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 52:188-195. 2011
- The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain. Journal of Orthopaedic Surgery and Research. 5:13. 2010
- Skeletal Scintigraphy in Pediatric Sports Medicine. American Journal of Roentgenology. 195:1212-1219. 2010
- Seasonal variation in the effect of constant ambient temperature of 24°C in reducing FDG uptake by brown adipose tissue in children. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. 37:1854-1860. 2010
- Constant ambient temperature of 24°C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. 36:602-606. 2009
- Endovascular Repair of Traumatic Mesocaval Fistula. Journal of Vascular and Interventional Radiology. 19:1659-1661. 2008
- Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT. Chest. 132:18-23. 2007
- Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia. 13:293-304. 2007
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literature. Gynecologic Oncology. 97:624-637. 2005
- Lateral diffusion of the total polar lipids from Thermoplasma acidophilum in multilamellar liposomes. Biochimica et Biophysica Acta - Biomembranes Biochimica et Biophysica Acta - Reviews on Biomembranes. 1369:259-266. 1998
-
chapter
- Molecular and Functional Imaging in Oncology Therapy Response. Medical radiology. 255-272. 2020
- Cardiac Imaging. 115-144. 2019
- Bladder carcinoma. 191-199. 2014
- Renal carcinoma. 179-190. 2014
- Sports Injuries. 385-396. 2014
- Cancers of the Esophagus and Small Bowel, Precancerous States of the Large Bowel, and Gastrointestinal Stromal Tumors. 423-450. 2013
- Radionuclide Therapy of Bone Metastases. 85-100. 2013
-
conference paper
- Bone scan use in the management of metastatic castration-resistant prostate cancer: Survey of practice patterns among Canadian radiation oncologists, medical oncologists, and urologists. Journal of the Canadian Urological Association. E601-E603. 2020
- Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study. Annals of Oncology. 2017
- An Approach to New Oncologic PET Agent Development. Journal of Nuclear Medicine. 2017
- Phase 1 study with expansion cohorts of cabozantinib (C) + abiraterone (A) in metastatic castration resistant prostate cancer (mCRPC): Investigator-sponsored study.. Journal of Clinical Oncology. 5037-5037. 2015
- Evaluation of refractory epilepsy in children using 3D-SSP (NEUROSTAT) and FDG-PET. Journal of Nuclear Medicine. 2014
- PET and MRI associations across a spectrum of pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC). Journal of Nuclear Medicine. 2014
- Prognostic value of baseline evaluation of FDG and NaF PET/CT in castrate-resistant prostate cancer (CRPC): Early results from a prospective phase 1 trial. Journal of Nuclear Medicine. 2014
- A practical approach to PET/MRI: Common abdominal pathology in oncology. Journal of Nuclear Medicine. 2013
- Abstract LB-166: Cabozantinib (cabo) + abiraterone (abi) combination therapy in castration resistant prostate cancer (CRPC): preclinical evaluation and interim results of an investigator-sponsored phase 1 clinical study.. Cancer Research. 2013
- Beyond Dose Guidelines: Lower Minimum Radiopharmaceutical Administered Doses in Pediatric Hepatobiliary Scintigraphy: Application of Enhanced Planar Processing.. European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine. S237-S237. 2012
- Role of CT, MRI, and PET/CT in Management of Myeloid Sarcoma With Clinical and Pathologic Correlation. American Journal of Roentgenology. 2012
- The Utility of Bone Scintigraphy in Pediatric Patients (CME Credit Available). American Journal of Roentgenology. 2009